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We report a molecule-scale controlled-release system based on
silica nanoparticles bearing a photoactive o-nitrobenzyl bromide
linkage, which allows cage and release of drug or biologically
active molecules by light.
Controlled-release systems which integrate external stimula-
tion with nanoscale carriers have attracted great attention
owing to their potential application in the area of drug
delivery.1 To date, various kinds of stimuli-responsive release
strategies have been proposed.1,2 Light-responsive controlled-
release systems possess several advantages, including their
non-invasive property, and unique site- and time-specificity.3,4
Recently, many kinds of light-responsive controlled-released
systems have been reported, such as coumarin-modified me-
soporous nanoparticles,3 photolabile gold nanoparticles,4 and
azobenzene-modified nanomaterials.5 However, the release of
guest molecules from these systems is indirect, and involves
previous unlocking of a molecular gate and subsequent release
of guest molecules. Systems releasing direct, trigger-precise
drug doses at a molecular level would be of great value for
drug delivery science, pharmaceutics, biomedicine and
molecular biology.6
Although molecular methods for light-triggered delivery of
drug and biologically active molecules have been proposed,6,7
construction of caged molecules can be costly and involves
complicated chemical design, synthesis and purification.
Furthermore, the caged molecules are not apt to be further
modified with various functions, such as fluorescent, magnetic
and targeted functions. A controlled-release system that inte-
grates a molecule-scale light-triggered device with a nanoscale
carrier would provide a means for overcoming these
challenges.
Herein, we report a molecule-scale controlled-release system
based on silica nanoparticles bearing a photoactive o-nitro-
benzyl bromide linkage, which allows cage and release of drug
or biologically active molecules by light. Construction of such
light-responsive silica nanoparticles does not involve compli-
cated chemical design, synthesis or purification processes.
Furthermore, numerous advantages of silica nanoparticles,8
including better biocompatibility, ease of functionalization
and surface modification, make it feasible for them to be
endowed with various functions and to be delivered into living
cells.
Silica nanoparticles functionalized with amino and methyl
phosphonate groups were synthesized in two steps using a
water-in-oil microemulsion system.9,10 The methyl phospho-
nate group is necessary to keep the particles well dispersed and
at the same time enable amine-based conjugation.10 Light-
responsive silica nanoparticles (structure is shown in Fig. 1)
were prepared by covalent conjugation of photoactive
o-nitrobenzyl bromide molecules with amino groups on the
particle surface.
High resolution transmission electron microscopy (TEM)
and absorption spectroscopy were used for the characteriza-
tion of the silica nanoparticles. Fig. 2a shows an example of a
TEM image of the silica nanoparticles. The average diameter
of the nanoparticles is about 70 nm. Absorption spectra shown
in Fig. 2b demonstrate the successful conjugation of o-nitro-
benzyl bromide molecules on the particle surface (details in the
ESIw).
The o-nitrobenzyl bromide groups can be used for the direct
cage of drug and biologically active molecules which contain
carboxylic, phosphate, or hydroxy groups.7 Drug and biolo-
gical active molecules can then be irreversibly released by
irradiation with light through light-induced photoisomeriza-
tion of the o-nitrobenzyl caged derivatives into o-nitrobenz-
aldehyde (Fig. 3).6,7
We performed controlled-release experiments with 5(6)-
carboxytetramethylrhodamine (CTMR), which is fluorescent
and contains one active carboxylic acid group as a model
molecule. CTMR molecules were caged on the surface of silica
nanoparticles on the molecule-scale through a direct esterifica-
tion process between 5(6)-carboxylic groups and surface
o-nitrobenzyl bromide groups.
Fig. 1 Structure of light-responsive silica nanoparticles.
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Fluorescence spectra shown in Fig. 4a indicate that CTMR
molecules can be effectively caged by o-nitrobenzyl bromide
group functionalized silica nanoparticles. A negligible fluores-
cence signal from silica nanoparticles without o-nitrobenzyl
bromide groups excludes the possibility of non-specific inter-
actions of CTMR with the particle surface. The inset of Fig. 4a
shows the structure of the o-nitrobenzyl caged CTMR. Ac-
cording to the fluorometric studies of the CTMR conjugated
silica nanoparticles, and assuming the density of silica nano-
particles is equal to pure silica,9 we have estimated that about
240 CTMR molecules were capable of binding to each nano-
particle.
To monitor the release process of the caged CTMR, we then
quantified the CTMR that was released by photolysis of the
light-responsive silica nanoparticles. After irradiation of an
aqueous solution of the caged CTMR with UV light with
wavelengths longer than 310 nm, the photoproduct, CTMR,
was isolated through centrifugation, and then diluted with
deionized water for fluorescence measurements. Control ex-
periments were carried out by monitoring the fluorescence of
the diluted solutions which were isolated from samples kept in
dark conditions. Fig. 4b gives the normalized fluorescence
emission spectra of the released CTMR after different dura-
tions of exposure to UV light. These fluorescence emission
spectra were normalized by subtracting the fluorescence sig-
nals obtained from the control experiments in order to mini-
mize the negative fluorescence signals from the incomplete
centrifugation process.
Further control experiments from samples exposed to per-
iods in light and dark conditions showed no detectable release
of CTMR in the period in dark conditions (Fig. 5), indicating
that no other release processes occur under dark conditions
and that liberation is temporally and spatially restricted to
regions to which light is applied. The inset of Fig. 4b shows the
correlation of integral fluorescence intensity of the released
CTMR with the duration of exposure to light. These pilot
studies of our controlled-release system demonstrate its ability
in the precise control of molecule liberation on the molecule-
scale. This system can also be extended to the cage and release
of other drug or biologically active molecules. In addition,
different from existing molecular methods for molecule libera-
tion, our system does not involve the release of the formed
o-nitrobenzaldehyde side-product under photolysis which can
be harmful in biological systems.
Silica nanoparticles were apt to be endowed with various
functions. Here we prepared light-responsive silica nanoparti-
cles doped with a fluorescent dye,9 tris(2,20-bipyridyl)
Fig. 2 (a) TEM image of the silica nanoparticles; (b) absorption
spectra of an aqueous solution of o-nitrobenzyl bromide (line 1), silica
nanoparticles (line 2), and silica nanoparticles conjugated with
o-nitrobenzyl bromide (line 3).
Fig. 3 Chemical structure of various types of o-nitrobenzyl caged
drug and biologically active molecules (top), and generalized photo-
chemical reaction of an o-nitrobenzyl caged derivative (bottom).
Fig. 4 (a) Fluorescence spectra of CTMR on the surface of silica
nanoparticles with (  ) and without (—) o-nitrobenzyl bromide
groups; (b) normalized fluorescence emission spectra of the released
CTMR after different durations of exposure to UV light. Inset:
correlation of integral fluorescence intensity of the released CTMR
with the duration of exposure to light.




























































dichlororuthenium(II) (RuBpy). The fluorescent silica nano-
particles were then used for the cage of an analgesic and anti-
inflammatory drug, ibuprofen, which contains one carboxylic
group. The drug-carrying silica nanoparticles were incubated
with RAW 264.7 cells for 24 h on plate and then washed with
phosphate buffered saline (PBS) to remove the non-interna-
lized nanoparticles. Fig. 6 shows the bright-field and fluores-
cence microscopy images of the incubated cells. As can be
seen, significant fluorescence was observed inside the cells,
indicating that drug-carrying silica nanoparticles functiona-
lized with fluorescent properties can be optically monitored
inside cells with confocal fluorescence microscopy. Silica
nanoparticles with fluorescent function will also provide a
promising platform to optically monitor intracellular traffick-
ing and real-time drug action.11
In conclusion, we have developed a new molecule-scale
controlled-release system based on light-responsive silica
nanoparticles which can be used for direct cage and release
of drug and biologically active molecules which contain
carboxylic, phosphate, or hydroxyl groups. The results repre-
sent a proof-of-concept for the cage and release of CTMR and
can be extended to other drug and biologically active mole-
cules. In addition, different from existing molecular methods
for molecule liberation, numerous advantages of silica nano-
particles allow our system to be endowed with various func-
tions,12 which will provide promising platforms for
multifunctional applications in drug delivery science, biome-
dicine and molecular biology.
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Fig. 5 Fluorescence emission spectra of released CTMR after periods
in light and dark conditions.
Fig. 6 Bright bright-field (left) and confocal fluorescence (right)
microscopy images of the incubated RAW 264.7 cells.
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